1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-8,9-dihydro-7H-pyrimido[5,4-h][1,5]benzoxazepin-6-yl]-4-(2-methyl-1-piperidyl)but-2-en-1-one

ID: ALA4646638

PubChem CID: 78322611

Max Phase: Preclinical

Molecular Formula: C34H35ClFN5O3

Molecular Weight: 616.14

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC1CCCCN1C/C=C/C(=O)N1CCCOc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc21

Standard InChI:  InChI=1S/C34H35ClFN5O3/c1-23-7-2-3-13-40(23)14-5-10-33(42)41-15-6-16-43-32-20-29-27(19-30(32)41)34(38-22-37-29)39-26-11-12-31(28(35)18-26)44-21-24-8-4-9-25(36)17-24/h4-5,8-12,17-20,22-23H,2-3,6-7,13-16,21H2,1H3,(H,37,38,39)/b10-5+

Standard InChI Key:  XNMMHZYSMCHVHQ-BJMVGYQFSA-N

Molfile:  

 
     RDKit          2D

 44 49  0  0  0  0  0  0  0  0999 V2000
    7.7386   -6.7655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7377   -5.1282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4467   -5.5360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4459   -6.3582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1570   -6.7662    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8695   -6.3571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8663   -5.5317    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1545   -5.1233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1517   -4.3020    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8622   -3.8910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5747   -4.3025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2846   -3.8922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2823   -3.0700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5641   -2.6599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8570   -3.0767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9977   -4.2987    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   11.9922   -2.6539    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.7059   -3.0633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4117   -2.6472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1225   -3.0607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8319   -2.6453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8284   -1.8231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1097   -1.4180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4032   -1.8316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5454   -3.0550    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.0377   -5.5388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0344   -6.3582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3889   -6.8724    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3933   -5.0233    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5869   -6.6920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5892   -5.2064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2332   -5.9498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3889   -4.2056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0945   -3.7933    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6791   -3.8008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9736   -4.2132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2637   -3.8084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5582   -4.2207    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8512   -3.8147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1478   -4.2236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1480   -5.0411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8577   -5.4481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5673   -5.0376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2774   -5.4419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 27  1  1  0
  1  4  2  0
  3  2  2  0
  2 26  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 12 16  1  0
 13 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 21 25  1  0
 26 27  2  0
 27 28  1  0
 26 29  1  0
 28 30  1  0
 29 31  1  0
 30 32  1  0
 31 32  1  0
 29 33  1  0
 33 34  2  0
 33 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 38 43  1  0
 39 40  1  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 43 44  1  0
M  END

Associated Targets(Human)

NCI-N87 (850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1975 (4994 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-431 (6446 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BT-474 (2113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Calu-3 (339 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 616.14Molecular Weight (Monoisotopic): 615.2412AlogP: 7.29#Rotatable Bonds: 8
Polar Surface Area: 79.82Molecular Species: BASEHBA: 7HBD: 1
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.70CX LogP: 6.44CX LogD: 5.13
Aromatic Rings: 4Heavy Atoms: 44QED Weighted: 0.21Np Likeness Score: -1.32

References

1. Sun M, Jia J, Sun H, Wang F..  (2020)  Design and synthesis of a novel class EGFR/HER2 dual inhibitors containing tricyclic oxazine fused quinazolines scaffold.,  30  (9): [PMID:32139324] [10.1016/j.bmcl.2020.127045]

Source